Syntilio, an Amsterdam, Netherlands-based health technology startup, raised an undisclosed amount in funding.
The round saw participation from NextGen Ventures 2 and a group of informal investors.
The company intends to use the funds for the expansion of the team and the development of new features and capabilities for the software platform.
Founded by Rimon Hanna who was recently joined by former FocusCura CEO Raoul Zaal, Syntilio provides a software platform that enables healthcare providers to remotely monitor patients and manage their care more efficiently. The platform enables healthcare providers to service remote patients and manage their care more efficiently. The platform uses technology to gather patient data and provide AI supported, real-time insights, allowing healthcare providers (“triagist”) to make more informed decisions, organise the right form of follow-up and provide better care.
FinSMEs